80 results
Page 4 of 4
424B3
iuiqtevf
28 Mar 12
Prospectus supplement
12:00am
20-F
2xow9qygep9g 17
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
7kr1u
22 Mar 12
BioLineRx Reports Fourth Quarter and Calendar 2011 Results
12:00am
6-K
EX-99
yexaadb lta1knpspgv1
7 Mar 12
BioLineRx Announces Grant of European Patent Covering
12:00am
6-K
EX-99
z9g6kd8ipog4t2b4
5 Mar 12
BioLineRx Receives Approval for Commencing
12:00am
6-K
EX-99
4kq 6ieon7l55rvk1e
6 Feb 12
Current report (foreign)
12:00am
6-K
EX-99
0mbmtz
23 Jan 12
BioLineRx Signs Exclusive License Agreement
12:00am
6-K
EX-99
l4z7w4bi9ex163
13 Dec 11
BioLineRx to Develop and Commercialize Novel Peptide
12:00am
6-K
EX-99
lz3geqw
5 Dec 11
BioLineRx Announces Positive Final Results from Phase Ia
12:00am
6-K
EX-1
366p3lt
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
6-K
EX-1
fuoe9sat3
26 Sep 11
BioLineRx to Present Data from the Successfully Completed
12:00am
6-K
EX-1
yii6zd 5a2auqlj28c
12 Sep 11
BioLineRx Announces Positive Preliminary Results from
12:00am
6-K
EX-1
qp7z9 puj6mj
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
6-K
EX-2
gnr2sj flnzzzyx3j
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
S-8
mhe6 g8lq06h
22 Aug 11
Registration of securities for employees
12:00am
20FR12B/A
ao3sutvzskuvzo
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
iue 7memnps
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
55vq2m9solil7e gqq9
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
saqp vzr51zsu1u8
24 Sep 10
Registration statement (foreign)
12:00am
F-1
7tv602lb34ygsay mzeb
24 Sep 10
Registration statement (foreign)
12:00am